UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 93

Sortiert nach

Get reliable laboratory findings - how to recognize the deceptive effects of angiotensin-converting enzyme inhibitor therapy in the laboratory diagnostics of sarcoidosis?

Clinical chemistry and laboratory medicine, 2024-06, Vol.62 (7), p.1393

2024

Volltextzugriff (PDF)

Optimized angiotensin-converting enzyme activity assay for the accurate diagnosis of sarcoidosis

Clinical chemistry and laboratory medicine, 2018-06, Vol.56 (7), p.1117

2018

Volltextzugriff (PDF)

Acute phase proteins in the diagnosis and prediction of cirrhosis associated bacterial infections

Liver international, 2012-04, Vol.32 (4), p.603-611

2012

Volltextzugriff (PDF)

In Vivo Target Sites of Nitric Oxide in Photosynthetic Electron Transport as Studied by Chlorophyll Fluorescence in Pea Leaves

Plant physiology (Bethesda), 2008-04, Vol.146 (4), p.1920-1927

2008

Volltextzugriff (PDF)

Utility of serological markers in inflammatory bowel diseases: gadget or magic?

World journal of gastroenterology : WJG, 2007-04, Vol.13 (14), p.2028

2007

Volltextzugriff (PDF)

Presence of anti-microbial antibodies in liver cirrhosis--a tell-tale sign of compromised immunity?

PloS one, 2010-09, Vol.5 (9), p.e12957-e12957

2010

Volltextzugriff (PDF)

Catheter-directed thrombolysis in inflammatory bowel diseases： Report of a case

World journal of gastroenterology : WJG, 2012-09, Vol.18 (34), p.4791-4793

2012

Volltextzugriff (PDF)

Combined application of angiotensin converting enzyme and chitotriosidase analysis improves the laboratory diagnosis of sarcoidosis

Clinica chimica acta, 2020-01, Vol.500, p.155-162

2020

Volltextzugriff (PDF)

Chitotriosidase gene polymorphisms and mutations limit the determination of chitotriosidase expression in sarcoidosis

Clinica chimica acta, 2021-02, Vol.513, p.50-56

2021

Volltextzugriff (PDF)

Fontolizumab in moderate to severe Crohn's disease: A phase 2, randomized, double‐blind, placebo‐controlled, multiple‐dose study

Inflammatory bowel diseases, 2010-02, Vol.16 (2), p.233-242

2010

Volltextzugriff (PDF)

Anti-microbial antibodies in celiac disease： Trick or treat

World journal of gastroenterology : WJG, 2009-08, Vol.15 (31), p.3891-3900

2009

Volltextzugriff (PDF)

norUrsodeoxycholic acid improves cholestasis in primary sclerosing cholangitis

Journal of hepatology, 2017-09, Vol.67 (3), p.549-558

2017

Volltextzugriff (PDF)

The PREDICT study uncovers three clinical courses of acutely decompensated cirrhosis that have distinct pathophysiology

Journal of hepatology, 2020-10, Vol.73 (4), p.842-854

2020

Volltextzugriff (PDF)

Phenotypic polymorphism of haptoglobin: A novel risk factor for the development of infection in liver cirrhosis

Human immunology, 2011-04, Vol.72 (4), p.348-354

2011

Volltextzugriff (PDF)

Ustekinumab as Induction and Maintenance Therapy for Ulcerative Colitis

The New England journal of medicine, 2019-09, Vol.381 (13), p.1201-1214

2019

Volltextzugriff (PDF)

Vedolizumab versus Adalimumab for Moderate-to-Severe Ulcerative Colitis

The New England journal of medicine, 2019-09, Vol.381 (13), p.1215-1226

2019

Volltextzugriff (PDF)

PREDICT identifies precipitating events associated with the clinical course of acutely decompensated cirrhosis

Journal of hepatology, 2021-05, Vol.74 (5), p.1097-1108

2021

Volltextzugriff (PDF)

Ozanimod as Induction and Maintenance Therapy for Ulcerative Colitis

The New England journal of medicine, 2021-09, Vol.385 (14), p.1280-1291

2021

Volltextzugriff (PDF)

ERCP is more challenging in cases of acute biliary pancreatitis than in acute cholangitis – Analysis of the Hungarian ERCP registry data

Pancreatology : official journal of the International Association of Pancreatology (IAP) ... [et al.], 2021-01, Vol.21 (1), p.59-63

2021

Volltextzugriff (PDF)

A randomized, open-label, non-inferiority study of intravenous iron isomaltoside 1,000 (Monofer) compared with oral iron for treatment of anemia in IBD (PROCEED)

The American journal of gastroenterology, 2013-12, Vol.108 (12), p.1877-1888

2013

Volltextzugriff (PDF)

Mannose-binding lectin level and deficiency is not associated with inflammatory bowel diseases, disease phenotype, serology profile, and NOD2/CARD15 genotype in a large Hungarian cohort

Human immunology, 2010-04, Vol.71 (4), p.407-413

2010

Volltextzugriff (PDF)

Evaluation of the Combined Application of Ethanol-Fixed and Formaldehyde-Fixed Neutrophil Substrates for Identifying Atypical Perinuclear Antineutrophil Cytoplasmic Antibodies in Inflammatory Bowel Disease

Clinical and Vaccine Immunology, 2009-04, Vol.16 (4), p.464-470

2009

Volltextzugriff (PDF)

Budesonide 9 mg Is at Least as Effective as Mesalamine 4.5 g in Patients With Mildly to Moderately Active Crohn's Disease

Gastroenterology (New York, N.Y. 1943), 2011-02, Vol.140 (2), p.425-434.e1

2011

Volltextzugriff (PDF)

Mirikizumab as Induction and Maintenance Therapy for Ulcerative Colitis

The New England journal of medicine, 2023-06, Vol.388 (26), p.2444-2455

2023

Volltextzugriff (PDF)

Haptoglobin polymorphisms are associated with crohn's disease, disease behavior, and extraintestinal manifestations in hungarian patients

Digestive diseases and sciences, 2007-05, Vol.52 (5), p.1279-1284

2007

Volltextzugriff (PDF)

1 – 25 von 93

Suche als RSS-Feed

Aktive Filter

KollektionTaylor & Francis Online

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(83)
Mit Volltextzugriff
(68)

Publikationsform

Artikel
(93)

Sprache

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Get reliable laboratory findings - how to recognize the deceptive effects of angiotensin-converting enzyme inhibitor therapy in the laboratory diagnostics of sarcoidosis?

Optimized angiotensin-converting enzyme activity assay for the accurate diagnosis of sarcoidosis

Acute phase proteins in the diagnosis and prediction of cirrhosis associated bacterial infections

In Vivo Target Sites of Nitric Oxide in Photosynthetic Electron Transport as Studied by Chlorophyll Fluorescence in Pea Leaves

Utility of serological markers in inflammatory bowel diseases: gadget or magic?

Presence of anti-microbial antibodies in liver cirrhosis--a tell-tale sign of compromised immunity?

Catheter-directed thrombolysis in inflammatory bowel diseases： Report of a case

Combined application of angiotensin converting enzyme and chitotriosidase analysis improves the laboratory diagnosis of sarcoidosis

Chitotriosidase gene polymorphisms and mutations limit the determination of chitotriosidase expression in sarcoidosis

Fontolizumab in moderate to severe Crohn's disease: A phase 2, randomized, double‐blind, placebo‐controlled, multiple‐dose study

Anti-microbial antibodies in celiac disease： Trick or treat

norUrsodeoxycholic acid improves cholestasis in primary sclerosing cholangitis

The PREDICT study uncovers three clinical courses of acutely decompensated cirrhosis that have distinct pathophysiology

Phenotypic polymorphism of haptoglobin: A novel risk factor for the development of infection in liver cirrhosis

Ustekinumab as Induction and Maintenance Therapy for Ulcerative Colitis

Vedolizumab versus Adalimumab for Moderate-to-Severe Ulcerative Colitis

PREDICT identifies precipitating events associated with the clinical course of acutely decompensated cirrhosis

Ozanimod as Induction and Maintenance Therapy for Ulcerative Colitis

ERCP is more challenging in cases of acute biliary pancreatitis than in acute cholangitis – Analysis of the Hungarian ERCP registry data

A randomized, open-label, non-inferiority study of intravenous iron isomaltoside 1,000 (Monofer) compared with oral iron for treatment of anemia in IBD (PROCEED)

Mannose-binding lectin level and deficiency is not associated with inflammatory bowel diseases, disease phenotype, serology profile, and NOD2/CARD15 genotype in a large Hungarian cohort

Evaluation of the Combined Application of Ethanol-Fixed and Formaldehyde-Fixed Neutrophil Substrates for Identifying Atypical Perinuclear Antineutrophil Cytoplasmic Antibodies in Inflammatory Bowel Disease

Budesonide 9 mg Is at Least as Effective as Mesalamine 4.5 g in Patients With Mildly to Moderately Active Crohn's Disease

Mirikizumab as Induction and Maintenance Therapy for Ulcerative Colitis

Haptoglobin polymorphisms are associated with crohn's disease, disease behavior, and extraintestinal manifestations in hungarian patients

Aktive Filter

Suchergebnisse filtern